Skip to main content
Skip to main content
HCA logo

HCA Healthcare, Inc. (HCA) Stock Analysis

$407.05 -$4.68 (-1.14%) |Exceptional · 84
HCA Healthcare, Inc. (HCA) bottom line: signals are mixed — the Council read leans Bullish Lean (72/100) while the AI fundamental score is 84/100 (grade A+); the two lenses disagree, so weigh the breakdown below. Strongest single signal: Growth Durability strong.
MCap: $88.1B| P/E Ratio: 12.9| Vol: 1.16M| Target: $537.13 (+32.0%)| 52-wk range: $330.00 – $556.52
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

HCA Healthcare, Inc. (HCA) trades at $407.05 with AI Score 84/100 (Grade A+). HCA Healthcare, Inc. Market cap: $88.1B, Sector: Healthcare.

Price as of Aug 20, 2026 · Last analyzed: May 10, 2026
HCA Healthcare, Inc. is a leading provider of healthcare services in the United States, operating a vast network of hospitals and outpatient facilities. With a strong focus on patient care and operational efficiency, HCA is positioned to capitalize on the growing demand for healthcare services.

HCA stock analysis for 2026: Analysts have set a consensus price target of $537.13 for HCA Healthcare, Inc., suggesting 32.0% upside from the current price of $407.05. The AI MoonshotScore is 84/100, indicating a strong bullish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.

Watch the HCA film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Bullish Lean 72/100 · A

HCA: 2/3 scored disciplines lean bullish. Dominant signal: Growth Durability strong.

How is this calculated? →
MoonshotScore · Growth Potential · 84/100
Business Quality
Moderate Is this a genuinely good business?
Financial Safety
Moderate Could this blow up on me?
Valuation
Moderate Am I paying a fair price?
Growth Durability
Strong Is the growth real and likely to last?
Momentum
Weak Is the market already moving on this?
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Ken Griffin
Bullish
Jim Simons
Neutral
Izzy Englander
Bullish
Seth Klarman
Neutral
Moon AI
Bullish
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Neutral
Margin of Safety
Undervalued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Why this analysis is different

  • A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

HCA Healthcare, Inc. (HCA) Healthcare & Pipeline Overview

CEOSamuel N. Hazen
Employees226,000
HeadquartersNashville, TN, US
IPO Year2011

HCA Healthcare, Inc. stands as a premier healthcare services provider in the U.S., operating a comprehensive network of hospitals and outpatient facilities, delivering a wide array of medical and surgical services while maintaining a focus on quality patient care and operational excellence.

Data Provenance | Financial Data Quantitative Analysis NYSE Analysis: May 10, 2026

What Is the Investment Thesis for HCA?

As of May 10, 2026 — figures reflect the data available on that date.

HCA Healthcare, Inc. presents a compelling investment thesis driven by its robust market position and operational efficiency. With a market capitalization of $88.1B and a P/E ratio of 12.9, HCA demonstrates strong profitability, evidenced by a profit margin of 8.9% and a gross margin of 34.9%. The company is well-positioned to benefit from the ongoing expansion of healthcare services, particularly as the demand for outpatient care continues to rise. HCA's strategic focus on operational excellence, combined with its extensive network of facilities, allows it to capture market share in an increasingly competitive landscape. Additionally, the company's dividend yield of 0.68% provides a steady income stream for investors. However, potential risks, including regulatory changes and market competition, must be monitored closely as they could impact future growth.

Based on FMP financials and quantitative analysis

HCA Key Highlights

Market capitalization of $88.1B indicates strong market presence in the healthcare sector.

  • P/E ratio of 12.9 reflects a competitive valuation relative to peers.
  • Profit margin of 8.9% demonstrates effective cost management and operational efficiency.
  • Gross margin of 34.9% exceeds industry averages, indicating strong profitability.
  • Dividend yield of 0.68% provides a steady return to shareholders.

Who Are HCA's Competitors?

HCA is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
PFE Pfizer Inc. $28.24 +3.63% $161B 67
BMY Bristol-Myers Squibb Company $65.47 -3.17% $134B 90
SNY Sanofi $45.44 -0.85% $109B 58
VRTX Vertex Pharmaceuticals Incorporated $552.06 +4.52% $140B 98
CVS CVS Health Corporation $93.65 -1.33% $119B 70
THC Tenet Healthcare Corporation $274.81 +2.34% $22.1B 86
SOLV Solventum Corporation $88.98 +1.33% $15.4B 56
EHC Encompass Health Corporation $120.91 -0.68% $12.0B 88

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are HCA's Key Strengths?

Large scale of operations with 182 hospitals and numerous outpatient facilities.

  • Strong financial performance with consistent revenue growth.
  • Diverse service offerings catering to a wide range of patient needs.
  • Established reputation for quality care and patient satisfaction.

What Are HCA's Weaknesses?

High operational costs associated with running extensive healthcare facilities.

  • Regulatory challenges in the healthcare industry may impact operations.
  • Dependence on government reimbursement programs for a significant portion of revenue.
  • Potential vulnerabilities to economic downturns affecting patient volumes.

What Could Drive HCA Stock Higher?

Expansion of outpatient services to meet rising patient demand.

  • Strategic acquisitions to enhance geographic reach and service offerings.
  • Investment in technology to improve operational efficiency and patient care.
  • Initiatives to expand mental health services in response to societal needs.

What Are the Key Risks for HCA?

Regulatory changes impacting reimbursement rates and operational practices.

  • Competition from other healthcare providers and emerging startups.
  • Economic fluctuations affecting patient volumes and insurance coverage.
  • Rising costs of healthcare delivery impacting profit margins.

What Are the Growth Opportunities for HCA?

  • By enhancing its outpatient facilities and services, HCA can attract more patients seeking convenient, cost-effective care options.
  • Technological Advancements in Healthcare: The integration of advanced technologies in healthcare delivery is expected to drive significant growth. HCA's investment in telehealth services and electronic health records positions the company to improve patient outcomes and operational efficiency, tapping into a market projected to grow at a CAGR of 15% through 2026.
  • Strategic Acquisitions: HCA has a history of strategic acquisitions that enhance its service offerings and geographic reach. With a focus on acquiring complementary healthcare facilities, HCA can expand its footprint in underserved markets, potentially increasing its patient base and revenue streams.
  • Aging Population: The increasing number of elderly individuals in the U.S. is expected to drive demand for healthcare services. HCA's comprehensive service offerings, particularly in geriatric care, position it to meet this rising demand, contributing to sustained revenue growth over the next decade.
  • Mental Health Services Expansion: HCA's operation of psychiatric hospitals allows it to address the growing need for mental health services, which is projected to grow to a $240 billion market by 2030. By enhancing its mental health programs, HCA can capture a larger share of this expanding market.

What Are HCA's Competitive Advantages?

  • Extensive network of hospitals and outpatient facilities enhances accessibility.
  • Strong brand recognition and reputation for quality care in the healthcare sector.
  • Diverse service offerings reduce dependency on any single revenue stream.
  • Operational efficiencies gained from scale provide a competitive advantage.
  • Commitment to innovation and technology adoption improves patient care.

What Does HCA Do?

HCA Healthcare, Inc., founded in 1968, is a prominent health care services company headquartered in Nashville, Tennessee. Originally known as HCA Holdings, Inc., the company has evolved significantly over the decades, expanding its operations to become one of the largest healthcare providers in the United States. HCA operates a diverse range of healthcare facilities, including general and acute care hospitals, outpatient surgery centers, and urgent care facilities, among others. As of December 31, 2021, HCA managed 182 hospitals, comprising 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals across 20 states and England. The company also boasts a robust network of outpatient healthcare facilities, including 125 freestanding surgery centers and 21 freestanding endoscopy centers. HCA's extensive service offerings encompass inpatient care, intensive care, cardiac care, diagnostic and emergency services, as well as outpatient services like laboratory, radiology, and physical therapy. HCA's commitment to providing high-quality healthcare is evident in its operational strategies and the therapeutic programs offered in its psychiatric hospitals, which cater to various demographics. With a workforce of approximately 320,000 employees, HCA is dedicated to advancing healthcare delivery and improving patient outcomes through its comprehensive and innovative services.

What Products and Services Does HCA Offer?

  • Operate general and acute care hospitals providing comprehensive medical services.
  • Offer outpatient services including surgery, laboratory, and rehabilitation.
  • Manage freestanding ambulatory surgery and emergency care centers.
  • Provide psychiatric care and substance abuse treatment programs.
  • Deliver diagnostic imaging and therapy services through specialized centers.
  • Engage in community health initiatives to improve overall public health.

How Does HCA Make Money?

  • Generate revenue through patient services in hospitals and outpatient facilities.
  • Offer specialized medical services that cater to diverse patient needs.
  • Leverage economies of scale across a large network of healthcare facilities.
  • Implement cost management strategies to enhance profitability.
  • Engage in partnerships and collaborations to expand service offerings.

What Industry Does HCA Operate In?

The healthcare industry, particularly the medical care facilities sector, is experiencing significant growth driven by an aging population and increasing demand for healthcare services. The market is projected to expand as technological advancements and shifts towards outpatient care reshape service delivery. HCA Healthcare, Inc. is strategically positioned within this landscape, leveraging its extensive network of hospitals and outpatient facilities to meet the evolving needs of patients. The competitive landscape includes major players like Pfizer Inc. (PFE), Bristol-Myers Squibb Company (BMY), Sanofi (SNY), Vertex Pharmaceuticals Incorporated (VRTX), and CVS Health Corporation (CVS), all vying for market share in a rapidly changing environment.

Who Are HCA's Key Customers?

  • Patients seeking inpatient and outpatient medical care.
  • Insurance companies providing coverage for healthcare services.
  • Government programs such as Medicare and Medicaid.
  • Employers offering health benefits to employees.
  • Community organizations and health agencies collaborating on public health initiatives.
AI Confidence: 73% Updated: May 10, 2026

Company Profile

HCA Healthcare, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Nashville, US. The company is led by CEO Samuel N. Hazen. HCA has traded publicly since 2011.

HCA Healthcare, Inc. Financial Trajectory

HCA Healthcare, Inc. (HCA) reported $20.23B in revenue for Q2 2026, reflecting 5.9% growth compared to the prior quarter. The company recorded net income of $1.70B, with diluted EPS of $7.62. Quarter-over-quarter revenue has been mixed, typical for a large-cap company operating in Healthcare. Across the four most recent quarters, HCA averaged $7.47 in diluted EPS.

How HCA Healthcare, Inc. Is Valued

HCA Healthcare, Inc. carries a market capitalization of $88.1B, placing it in the large-cap category. Relative to its peer group, HCA's quantitative score of 84/100 is roughly in line with the peer average of 77/100.

P/E 12.9

Key Financial Metrics

Return on assets is 11.3%, showing how much profit it generates from its asset base. HCA trades at a trailing price-to-earnings ratio of 12.95, below the Healthcare sector average of ~23x. Its free cash flow yield is 6.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.78 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 7.5%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 7/9

Financial Health

HCA Healthcare, Inc.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 2.55 places it in the grey zone, a middle ground that warrants monitoring.

5/8 beats

Earnings Track Record

HCA Healthcare, Inc. has beaten Wall Street's EPS estimate in 5 of its last 8 reported quarters — more hits than misses. Reported results have landed about 6.4% above estimates on average.

FY2026 est

Forward Outlook

Wall Street analysts project HCA Healthcare, Inc. revenue of about $78.50B for fiscal 2026, with EPS near $29.57. The estimate reflects 18 contributing analysts.

Net buying

Insider Activity

Over the past six months, HCA Healthcare, Inc. insiders filed 10 SEC Form 4 transactions — 1 sales and 9 purchases. On net that is roughly 6K shares acquired (about $0) — insiders putting money in tends to read as conviction.

HCA Financials

HCA earnings history & estimates →

Fundamental Snapshot

Revenue Growth (FY)
+7.1%
Net Income Growth (FY)
+17.8%
EPS Growth (FY)
+28.5%
Free Cash Flow Growth (FY)
+36.4%
P/E (TTM)
13.3
Return on Equity (TTM)
-112.9%
Current Ratio
0.8
EV/EBITDA (TTM)
8.7

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • HCA's insider activity suggests confidence, with recent buying possibly signaling undervaluation.
  • Community sentiment leans bullish, fueled by positive perceptions of HCA's stability in the healthcare sector.
  • Market perception views HCA as a defensive play, attractive during economic uncertainty. Think healthcare demand is relatively constant.
  • Bullish voices highlight HCA's strong market position and ability to navigate regulatory changes.

Bear Case

  • Recent insider selling may indicate concerns about future performance or market conditions.
  • Bearish community members express concerns about rising costs and potential margin compression.
  • Market perception acknowledges regulatory risks and potential impacts on HCA's profitability.
  • Bearish voices point to increasing competition and potential challenges in maintaining market share.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 2026 $20.23B $1.70B $7.62
Q1 2026 $19.11B $1.62B $7.15
Q4 2025 $19.51B $1.88B $8.14
Q3 2025 $19.16B $1.64B $6.96

Based on FMP financials and quantitative analysis

HCA Latest News

HCA Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for HCA.

Price Targets

Consensus target: $537.13

HCA MoonshotScore

84/100

What does this score mean?

The MoonshotScore rates HCA 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

Latest HCA Healthcare, Inc. Analysis

Leadership: Samuel N. Hazen

CEO

Samuel N. Hazen has been with HCA Healthcare for over 30 years, holding various leadership roles that have shaped the company's strategic direction. He holds a Bachelor of Science in Business Administration from the University of Florida and has extensive experience in healthcare management and operations.

Track Record: Under Hazen's leadership, HCA has achieved significant operational efficiencies and expanded its service offerings, enhancing patient care and satisfaction. He has been instrumental in driving HCA's growth strategy, including strategic acquisitions and technological advancements.

Common Questions About HCA (Healthcare)

What does the AI Score mean for HCA?

HCA holds an AI Score of 84/100 (Grade: A+). This is an educational research signal, not a buy or sell recommendation. HCA Healthcare, Inc. is a leading provider of healthcare services in the United States, operating a vast network of hospitals and outpatient facilities. With a strong focus on patient care …

What does HCA Healthcare, Inc. do?

HCA Healthcare, Inc. operates a comprehensive network of hospitals and outpatient facilities across the United States. The company provides a wide range of healthcare services, including inpatient and outpatient care, surgical services, psychiatric treatment, and rehabilitation. With a focus on quality patient care, HCA is dedicated to improving health outcomes through its extensive service offerings.

What do analysts say about HCA stock?

Analysts generally view HCA Healthcare, Inc. positively, citing its strong market position and financial performance. Key valuation metrics indicate a P/E ratio of 12.9, which is competitive within the industry. Analysts highlight the company's growth potential driven by increasing demand for healthcare services and operational efficiencies, while also noting the need to monitor regulatory risks.

What are the main risks for HCA?

HCA Healthcare, Inc. faces several risks that could impact its business operations and financial performance. Regulatory changes in the healthcare industry may affect reimbursement rates, while competition from other healthcare providers could pressure market share. Additionally, economic fluctuations may influence patient volumes and insurance coverage, posing challenges to revenue stability.

What are the key factors to evaluate for HCA?

HCA Healthcare, Inc. (HCA) holds an AI score of 84/100 (high). P/E: 12.9x vs the S&P 500's ~20-25x. Analysts target $537.13 (+32%). Not financial advice.

How frequently does HCA data refresh on this page?

HCA's price was last updated on Aug 20, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven HCA's recent stock price performance?

HCA Healthcare, Inc. (HCA) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Large scale of operations with 182 hospitals and numerous outpatient facilities. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider HCA overvalued or undervalued right now?

HCA Healthcare, Inc. (HCA) trades at 12.9x earnings. Analysts target $537.13 (+32%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research HCA before investing?

Before investing in HCA Healthcare, Inc. (HCA), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • All information is based on the latest available data and may be subject to change.
Data Sources

Popular Stocks

More Stocks We Cover